Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
about
Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migrationThe future role of personalized medicine in the treatment of glioblastoma multiformeVoting-based cancer module identification by combining topological and data-driven propertiesBayesian methods for expression-based integration of various types of genomics data.Identifying disease-associated pathways in one-phenotype data based on reversal gene expression orderings.Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levelsU-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.Thrombin-induced Migration and Matrix Metalloproteinase-9 Expression Are Regulated by MAPK and PI3K Pathways in C6 Glioma Cells.Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsMicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.Gene therapy for malignant glioma.Deletion or epigenetic silencing of AJAP1 on 1p36 in glioblastoma.Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo.Tyrphostin AG 1296 induces glioblastoma cell apoptosis in vitro and in vivo.Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.MicroRNA-544 inhibits glioma proliferation, invasion and migration but induces cell apoptosis by targeting PARK7NF-kappaB and STAT3 signaling in glioma: targets for future therapiesCurrent clinical development of PI3K pathway inhibitors in glioblastoma.Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.Role of tenascins in the ECM of gliomas.The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells.Splicing factor hnRNPH drives an oncogenic splicing switch in gliomasWWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignantEffect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomasNecroptosis is associated with low procaspase-8 and active RIPK1 and -3 in human glioma cells.Viability reduction and Rac1 gene downregulation of heterogeneous ex-vivo glioma acute slice infected by the oncolytic Newcastle disease virus strain V4UPMNanomedicine associated with photodynamic therapy for glioblastoma treatment.The biology and mathematical modelling of glioma invasion: a review.AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.Prognostication of Survival Outcomes in Patients Diagnosed with Glioblastoma.Personalized medicine in neuro-oncology.Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway.MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling.Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles.
P2860
Q24632320-EEF0131A-734A-4C3A-BB07-F5B84714AA7EQ28391635-9E50AF5C-A337-4F3A-9C37-0EA218CE6BF6Q30661179-DAA878E7-8AF2-46E2-B690-10AD27BC8660Q30668548-809EE354-2EEF-4026-A019-BCF70AB15BD6Q33683844-3FFDEDF1-6BC3-4D03-8537-A40C0E8D9FEDQ34430791-EFAD77AC-2B2A-4314-8D54-3ABD79E4B8AAQ35000404-3E5C72B4-E708-4D05-9564-346AE97EDBB4Q35270062-82BBB7A8-8486-4D28-BC7E-1EE097A96E1FQ35356484-90EECC12-FA98-4823-8920-5135E9A4A953Q35545752-23BD2E51-C182-4624-BA24-58015DC03589Q35580808-BA80489E-9F18-478E-B130-35F2CE42081CQ35673628-6647CAB8-0C87-4F24-8312-4521B3014512Q35783190-4A2C8852-3864-415F-BE97-BA8078BB15D4Q35914525-364F5978-8123-4A73-B01B-610DA45D478FQ36334429-86813240-3821-47B1-844D-F541FCE62ABDQ36650919-3DFD67A0-D795-45CD-A5F4-241F33763470Q36879610-9999000E-E0F2-4ABB-8C92-83D7D7456C2CQ37457873-E61CBE00-AF28-4BA6-8FF8-CA881FA9B162Q38012438-148C31C0-B26A-4D2A-A2BA-8C76E32D9BCFQ38253056-97E1EA2E-482E-4E6D-9767-22EDDA65BE10Q38361238-46D1ED26-D6F2-42A2-A9A2-9376B13F8D26Q38941959-57382F8E-A2C6-4C63-9D2D-2306EFA40377Q38967517-85C4C409-AF5B-4E90-9494-61E75BD3C9B3Q38972730-2385A92E-1206-4222-AD01-69698E15BDE9Q39660159-A49619C5-2059-4218-8B6C-B09DF51B1B3CQ41575088-41F94F6D-1955-40BF-B8D5-BDF23ABFA399Q41976320-E1450044-FC20-4BB6-8F9B-D1BA2D062A2DQ47097576-6CEC9C35-D59D-4B3A-96E1-26B6801F005BQ47124238-A4D36B36-57E1-4BF2-B042-A6D8492563ACQ47426654-1161F19A-EAB5-4E3A-9911-AD979973DE26Q47798259-2D6D57E7-8614-4671-B6D4-47388A4A8772Q47916539-7F8A3C67-B78A-4BBA-96A3-5B0F43875C27Q48822128-4089E035-D07C-4D5C-956A-3887FE0D4F20Q49533311-E560695F-3998-4451-AFF1-32239B8F275DQ50017399-6C57127B-9BE4-41DC-A96E-B080EEAD0104Q55513456-51598448-C919-4B7F-B637-C6C01E270B3E
P2860
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@en
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@nl
type
label
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@en
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@nl
prefLabel
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@en
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@nl
P2093
P2860
P1476
Glioblastoma Multiforme Oncogenomics and Signaling Pathways.
@en
P2093
Betsy Hughes
Chunhui Di
Cory Adamson
Jinrong Fu
Ningjing Lin
Okezie O Kanu
P2860
P577
2009-04-01T00:00:00Z